Understanding the mechanisms behind this association, particularly in the context of APOE-ɛ4, is crucial for developing targeted interventions to mitigate the impact of chronic pain on cognitive function and Alzheimer’s disease progression. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.